To overcome this limitation, some reports have tested the use of GM-CSF in combination with IL-12 or the GM-CSF sequence inserted into an oncolytic virus vector to achieve synergistic antitumour effects on HCC models [60, 61]. Here, CSF2 is linked to hepatocellular carcinoma.